You searched for "Implant"

2338 results found

Isshiki Thyroplasty Type 2

Indication Adductor spasmodic dysphonia is a neurological condition of unknown aetiology. The symptoms are believed to be caused by involuntary contraction of the adductor muscles of the vocal cord as a result of an abnormality of neurotransmitters in the basal...

Adult hearing screening: consideration for a holistic model

Background Adult-onset hearing impairment is a highly prevalent and undertreated chronic problem that poses a significant burden of disease worldwide [1]. It is usually gradual and diagnosed and managed approximately 10 years after adults have first experienced hearing difficulties [2]....

Why hearing above 8 kHz matters more than you think

This review explores the significance of extended high-frequency hearing loss (above 8 kHz) and why it may be worth doing clinically more frequently. There are many conditions that may hide underneath a normal audiogram, and one of the easiest to...

Trainee-led collaborative research and audit in ENT: where are we now?

In late 2015 INTEGRATE, the UK ENT Trainee Research Network, was formed. Since then, two national projects have been completed and INTEGRATE has grown into a larger, more structured organisation, with otology, head and neck and rhinology subcommittees working alongside...

Minimally invasive craniotomy for middle fossa dura repair using the exoscope

A minimally invasive temporal craniotomy using an exoscope offers improved visualisation, ergonomics and recovery for middle fossa dural CSF leak repair. Cerebrospinal fluid (CSF) leak through a dural defect, regardless of the cause, typically requires surgical repair. Depending on the...

Lenire as a clinical tool for treatment of tinnitus

Lenire offers a promising but varied solution for tinnitus relief. Peter Byrom shares insights on its effectiveness, challenges and patient outcomes. I have been involved in tinnitus support for at least 20 years, including a stint on the then British...

Cutting Edge Laryngology 2026

Cutting Edge Laryngology 2026 is the bi-annual flagship meeting of the British Laryngological Association, bringing together an international faculty of leading experts in laryngology. This three-day conference will take place at the Royal Society of Medicine and will focus on the very latest advancements in voice, airway, and swallowing disorders. The programme will span clinical practice, scientific research, and technological innovation, featuring keynote lectures, original research presentations, case discussions, and panel debates. Designed for ENT surgeons, Speech and Language Therapists, Respiratory Physicians, Gastroenterologists, trainees, and allied health professionals, Cutting Edge Laryngology 2026 offers a unique opportunity for in-depth learning, cross-disciplinary debate, and international networking.

2020 Unmasked: The unmasking of a masked society - By Rele Ologunde

The year 2020 will be embossed in the archives of history and be remembered like none other before it. The dialogue will largely be centred upon the COVID-19 pandemic, the varied response to it by governments across the world and...

The Royal College of Surgeons of Edinburgh: Foundations in Surgical Leadership June 26

The Royal College of Surgeons of Edinburgh Foundations in Surgical Leadership

The Royal College of Surgeons of Edinburgh: Foundations in Surgical Leadership April 26

Royal College of Surgeons Edinburgh Foundations in Surgical Leadership

Paediatric nasopharyngeal carcinoma

Between 11 and 18% of nasopharyngeal carcinomas (NPC) occur in the paediatric age group but there are no specific management guidelines for this age group. Tunisia is a region with an intermediate incidence of NPC, the authors studied 40 cases...

Head and neck myxofibrosarcoma: a case report and review of the literature

Myxofibrosarcoma is the most common soft tissue sarcoma that occurs in late adult life, peaking in the seventh decade, and it is mainly encountered in the lower extremities. Cases within the head and neck region are extremely rare and to...